Literature DB >> 7931859

Evaluation and treatment of mood and anxiety disorders in opioid-dependent patients.

E V Nunes1, S J Donovan, R Brady, F M Quitkin.   

Abstract

Mood and anxiety disorders are common and treatable but may cause considerable morbidity if left untreated. This is especially so in opioid-dependent individuals, for whom diagnosis is difficult and rehabilitation easily compromised. Clinicians need guidelines to distinguish the patient with an independent mood or anxiety disorder from the more common anxious or depressed addict who is withdrawing, intoxicated or reacting to a life crisis. This article reviews the current knowledge of diagnosis, clinical presentation, and prevalence of mood and anxiety disorders common among opioid-dependent patients. It attempts to identify features of a patient's history that distinguish truly independent disorders and proceeds to a discussion of treatment approaches for this subgroup.

Entities:  

Mesh:

Year:  1994        PMID: 7931859     DOI: 10.1080/02791072.1994.10472262

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  2 in total

1.  Bupropion in the treatment of problematic online game play in patients with major depressive disorder.

Authors:  Doug Hyun Han; Perry F Renshaw
Journal:  J Psychopharmacol       Date:  2011-03-29       Impact factor: 4.153

2.  The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients.

Authors:  Victoria Wapf; Michael Schaub; Beat Klaeusler; Lukas Boesch; Rudolf Stohler; Dominique Eich
Journal:  Harm Reduct J       Date:  2008-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.